Longchain polyunsaturated fatty acid supplementation in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Longchain Polyunsaturated Fatty Acid Supplementation in Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440190/1/Siponimod_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed 28 March 2024.
Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440190/1/Siponimod_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed March 28, 2024.
Longchain polyunsaturated fatty acid supplementation in preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440190/1/Siponimod_for_multiple_sclerosis_Edited__no_change_to_conclusions_
Longchain Polyunsaturated Fatty Acid Supplementation in Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440190/1/Siponimod_for_multiple_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Longchain polyunsaturated fatty acid supplementation in preterm infants
ID - 440190
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440190/1/Siponimod_for_multiple_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -